Sensex: 83,606.46 (0.11%)

Nifty: 25,541.80 (0.10%)

anubhai angaldas Securities Pvt. Ltd. Member: BSE - NSE - CDSL

Technology . Transparency . Trust

Contact Us
Apply For IPO

MARKET

IPO Synopsis
Suraksha Diagnostic Ltd
Registered Office: Plot No DG-12/1 Action Area 1D, Premieses No 02-0327 Rajarhat, Kolkata - 700156, West Bengal
Phone: 1
Email: 1
Website: 1
Initial public offering of 19,189,330 equity shares of face value of Rs. 2 each of Suraksha Diagnostic Limited (the "Company" or the "Issuer") for cash at a price of Rs. 441 per equity share (including a premium of Rs. 439 per equity share) (the "Offer Price") aggregating to Rs. 846.25 crores through an offer for sale of 19,189,330 equity shares of face value of Rs. 2 each aggregating to Rs. 846.25 crores, comprising 2,132,148 equity shares of face value of Rs. 2 each aggregating to Rs. 94.03 crores by Somnath Chatterjee, 2,132,148 equity shares of face value of Rs. 2 each aggregating to Rs. 94.03 crores by Ritu Mittal, 2,132,148 equity shares of face value of Rs. 2 each aggregating to Rs. 94.03 crores by Satish Kumar Verma (whose shares are jointly held with Suman Verma) (together with Somnath Chatterjee and Ritu Mittal, the "Promoter Selling Shareholders"), 10,660,737 equity shares of face value of Rs. 2 each aggregating to Rs. 470.14 crores by Orbimed Asia ii Mauritius Limited^ (the "Investor Selling Shareholder"), 799,556 equity shares of face value of Rs. 2 each aggregating to Rs. 35.26 cores by Munna Lal Kejriwal, and 1,332,593 equity shares of face value of Rs. 2 each aggregating to Rs. 58.77 crores by Santosh Kumar Kejriwal (together the "Individual Selling Shareholders") (the promoter selling shareholders, the investor selling shareholder and the individual selling shareholders, collectively referred to as the "Selling Shareholders", and such equity shares offered by the selling shareholders, the "Offered Shares") (the "Offer" or the "Offer for Sale"). The offer constitutes 36.84% of the post-offer paid-up equity share capital of the company. ^ Surviving entity pursuant to amalgamation of orbimed Asia ii Mauritius fdi investments limited, the erstwhile shareholder, into orbimed asia ii mauritius limited on november 11, 2022 The face value of the equity shares is Rs. 2 each and the offer price is 220.5 times the face value of the equity shares.
Issue Money Payable On
Opens On Closes On Application Allotment
29-Nov-2024 03-Dec-2024 441.00 - 0.00 0.00 - 0.00
Cr. Lead Managers to the Issue
Project Cost 0.00
Project Financed through Current Offer 846.25
Post Issue Equity Share Capital 14.25
Issue Price 441.00
Projects
Listing the Equity Shares on the Stock Exchanges
Promoted By
Somnath Chatterjee
Ritu Mittal
Satish Kumar Verma
BSE
NSE
Registrar to the Issue
Attention Investor
As per CDSL communiqué Kindly update your Email ID, Mobile Number & Income Range in CDSL demat Account on or before 31st May 2021, Non Compliance Account will be INACTIVE after 31st May 2021. | Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors.  | "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account." | "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."    Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of Investors.